Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba 260-8675, Japan.
Research & Development Headquarters, House Foods Group Inc., 1-4, Takanodai, Yotsukaido-shi, Chiba 284-0033, Japan.
Langmuir. 2022 Aug 30;38(34):10454-10464. doi: 10.1021/acs.langmuir.2c01199. Epub 2022 Aug 17.
In this study, we prepared drug-loaded nanocarriers made of cholesteryl oleate (ChO) and γ-cyclodextrin (γ-CD). A nanosuspension (nanosuspension-I, NS-I) containing nanoparticles with a mean size of approximately 170 nm was obtained through the solvent-diffusion method using ethanol. A second nanosuspension (nanosuspension-II, NS-II), which was prepared by freeze-drying and redispersion of NS-I, exhibited an increased particle size of approximately 210 nm. Cryogenic transmission electron microscopy (cryo-TEM) and atomic force microscopy (AFM) force-distance curves indicated that the nanoparticles in NS-I were oblong and soft. However, those in NS-II were angular and stiff, and, interestingly, multiple nanosheets covered the solid-liquid interface. Synchrotron wide-angle X-ray diffraction (WAXD) analysis of NS-II indicated that the nanoparticles in it had a core-shell structure, where the ChO crystal in the inner core was covered by multiple nanosheets of ChO/γ-CD inclusion complex crystals. The X-ray peak analysis suggested that the γ-CD columns of the nanosheets were vertically stacked onto the ChO crystal interface. It was found that the nanosheets on the nanoparticle interface were formed during the freezing process. A model drug carbamazepine (CBZ) was loaded into the ChO/γ-CD nanoparticles by pre-dissolving CBZ in ethanol during the solvent-diffusion process. Cryo-TEM, H NMR, ζ-potentials, and synchrotron WAXD indicated that CBZ was unexpectedly loaded into the shell as a CBZ/γ-CD inclusion complex crystalline nanosheet. The specific nanosheet structure, where ChO and CBZ coexisted in the same crystal of γ-CD, could achieve CBZ loading in the nanoparticles. ChO/γ-CD nanoparticles with the unique core-shell structure are expected to perform as practical carriers for drug delivery.
在这项研究中,我们制备了由油醇酯(ChO)和γ-环糊精(γ-CD)制成的载药纳米载体。通过使用乙醇的溶剂扩散法获得了含有平均粒径约为 170nm 的纳米颗粒的纳米混悬液(纳米混悬液-I,NS-I)。通过冷冻干燥和 NS-I 的再分散制备的第二种纳米混悬液(纳米混悬液-II,NS-II)的粒径增加到约 210nm。低温透射电子显微镜(cryo-TEM)和原子力显微镜(AFM)力距离曲线表明,NS-I 中的纳米颗粒呈长形且柔软。然而,NS-II 中的纳米颗粒呈角形且坚硬,有趣的是,多个纳米片覆盖了固液界面。NS-II 的同步宽角 X 射线衍射(WAXD)分析表明,其中的纳米颗粒具有核壳结构,内核中的 ChO 晶体被多个 ChO/γ-CD 包合物晶体的纳米片覆盖。X 射线峰分析表明,纳米片的γ-CD 柱垂直堆叠在 ChO 晶体界面上。发现纳米片是在冷冻过程中在纳米颗粒界面上形成的。模型药物卡马西平(CBZ)通过在溶剂扩散过程中预先将 CBZ 溶解在乙醇中加载到 ChO/γ-CD 纳米颗粒中。Cryo-TEM、H NMR、ζ-电位和同步 WAXD 表明,CBZ 出人意料地作为 CBZ/γ-CD 包合物结晶纳米片负载在壳中。ChO 和 CBZ 共存于同一 γ-CD 晶体中的特殊纳米片结构可以实现纳米颗粒中 CBZ 的负载。具有独特核壳结构的 ChO/γ-CD 纳米颗粒有望成为药物输送的实用载体。